Recommend MiraLAX® to liberate your patients from occasional constipation and put them in control of their condition

• In multiple clinical trials, MiraLAX has been proven to1-9:
— Increase water content and volume of stool
— Soften stool to ease passage
— Result in a bowel movement within 24-72 hours
of an oral dose
— Increase the frequency of bowel movements

• In clinical studies, MiraLAX was well tolerated and had a low incidence of adverse events1-9

• MiraLAX can cost as little as 49¢ per dose*— an economical choice for your patients with occasional constipation

Restore your patients’ natural rhythm™

*Based on retail price of MiraLAX 30-dose, 17. 9 oz. (510 g) twin pack at leading club store.

Use as directed.

References: 1. Stoltz R, et al. An efficacy and consumer preference study of polyethylene glycol 3350 for the treatment of constipation in regular laxative users. Home Health Care Consultant. 2001;8: 21-26. 2. Cleveland MvB, et al. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001;94: 478-481. 3. Data on file, Schering-Plough HealthCare Products. 4. Di Palma JA, et al. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther. 2006;25:703-708. 5. DiPalma JA, et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol. 2007;102:1436-1441. 6. DiPalma JA, et al. A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation. Am J Gastroenterol. 2007;102:1964-1971. 7. DiPalma JA, et al. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol. 2000;95:446-450. 8. DiPalma JA, et al. Braintree polyethylene glycol (PEG) laxative for ambulatory and long-term care facility constipation patients: report of randomized, cross-over trials. Online J Dig Health.1999;1: 1-7. 9. Tran LC, et al. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation. J Clin Gastroenterol. 2005;39:600-602.